Home Attorney Profiles Past Successes Current Cases Frequently Asked Questions Contact Us
Learn about potential cases under investigation Have an attorney evaluate your potential case

Practice Areas

Consumer Fraud
Class Action Defense
Defective Products
General Civil Litigation
Qui Tam/False Claims Act
Real Estate
Contact Us
Tell Me About Your Case:


Pharmaceuticals Cases

Neurontin Marketing and Sales Practices Litigation. In 2010, Barry was part of the Boston trial team that obtained a $142 million verdict for Kaiser Foundation, a non-profit health care provider, against Pfizer for deceptive marketing of Neurontin (an anti-epileptic) to physicians for unapproved uses for which it was not effective. The landmark judgment was the first time a pharmaceutical company had been held liable under the RICO statute.

Vytorin/Zetia Marketing and Sales Practices Litigation. Barry represented consumers of these cholesterol medications in a case alleging that the manufacturer delayed publication of a study showing that the combination drug was no more effective than generic simvastatin in reducing arterial plaque and heart disease. The case settled in 2010 for $27 million.

Synthroid Marketing Litigation. Barry was co-lead counsel in a class action against the manufacturer of the popular thyroid medication, who suppressed the publication of a study showing that a less expensive generic could be safely substituted. The $88 million settlement was distributed to consumers in 2003.

The Towers
2000 Powell St.
Suite 1605
Emeryville, CA 94608-1861
510.450.0782 (phone)
510.924.0403 (fax)